NLS Pharmaceutics Ltd (NLSP)

3.365 +0.08 (+2.28%) USD  |  NASDAQ  |  Nov 21, 16:00
3.17 -0.20 (-5.79%) Pre-Market: 20:00
More

NLS Pharmaceutics EV to Assets (Quarterly)

EV to Assets (Quarterly) Chart

View EV to Assets (Quarterly) for NLSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EV to Assets (Quarterly) Data

View and export this data back to . Upgrade now.
Date Value

Enterprise Value Ratios (EV) Definition

Enterprise Value/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.

Read full definition.

EV to Assets (Quarterly) Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

EV to Assets (Quarterly) Benchmarks

AC Immune SA Upgrade
CRISPR Therapeutics AG Upgrade
Addex Therapeutics Ltd Upgrade
Molecular Partners AG Upgrade
MoonLake Immunotherapeutics --

EV to Assets (Quarterly) Related Metrics

EV to Free Cash Flow Upgrade